ArticleJournal of biosciences2016
PluriPred: AWeb server for predicting proteins involved in pluripotent network.
Article in Journal of biosciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- [Identification of potential regulatory genes for embryonic stem cell self-renewal and pluripotency by random forest].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pluripotency is a unique property of stem cells that allows them to differentiate into all types of adult cells or maintain the self-renewal property. PluriPred predicts whether a protein is involved in pluripotency from primary protein sequence using manually curated pluripotent proteins as training datasets. Machine learning techniques (MLTs) such as Support Vector Machine (SVM), Naïve Base (NB), Random Forest (RF), and sequence alignment technique BLAST were used in our study. The combination of SVM and PSI-BLAST was our proposed best model, which obtained a sensitivity of 77.40 percent, specificity of 79.72 percent, accuracy of 79.2 percent, and area under the ROC curve was 0.82 using 5-fold cross-validation. Furthermore, PluriPred gives the confidence of the prediction from training dataset's SVM score distribution and p-value from BLAST. We validated our proposed model with the other existing highthroughput studies using blind/independent datasets. Using PluriPred, 233 novel core and 323 novel extended core pluripotent proteins from mouse proteome, and 167 novel core and 385 extended core pluripotent proteins from human proteome, were predicted with high confidence. The Web application of PluriPred is available from bicresources. jcbose.ac.in/ssaha4/pluripred/. Many pluripotent genes/proteins take part in protein-protein networks associated with stem cell, cancer, and developmental biology, and we believe that PluriPred will help in these research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.